| Customization: | Available |
|---|---|
| Dosage Form: | Injection |
| Dossier: | Ready |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Generic Name | Paediatric Compound Amino Acid Injection 20ml:1.348g |
| Strength | 20ml:1.348g |
| Packing | 5ampoules/box |
| Origin | China |
This product is a compound preparation, which is a sterilized water solution prepared by 15 kinds of amino acids, and its group is divided into 1000ml
L-proline (C5H9NO2) 8.0g
L-serine (C3H7NO3) 5.0g
L-alanine (C3H7NO2) 7.7g
L-arginine (C6H14N4O2) 6.0g
L-histidine (C6H9N3O2) 2.4g
L-tryptophan (C11H12N2O2) 0.66g
L-valine (C5H11NO2) 8.4g
L-threonine (C4H9NO3) 4.5g
L-leucine (C6H13NO2) 11.0g
L-methionine (C15H11NO2S) 1.0g
L-isoleucine (C6H13NO2) 9.0g
L-phenylalanine (C9H11NO2) 1.0g
L-lysine acetate (C6H14N2O2·C2H4O2) 8.6g
L-cysteine hydrochloride (C3H7NO2S·HCl) < 0.2 g
Glycine (C2H5NO2) 9.0g
Sodium bisulfite (NaHSO3) 0.5g
Amino acid drugs. It is used for patients with insufficient protein intake, absorption disorders and other amino acids that cannot meet the metabolic needs of the body. It is also used to improve the nutritional status of patients after surgery.
Usage and dosage:
Intravenous drip, 250 ~ 500ml a day. Appropriate 5% ~ 10% glucose injection was mixed and slowly injected. Drop rate should not exceed 20 drops per minute.
Adverse reaction broadcasting
This product can cause rash - like allergic reactions, once the occurrence should be discontinued. Occasionally nausea, vomiting, chest tightness, palpitation, chills, fever or headache.
Taboo broadcasting
It is contraindicated in patients with severe hepatic and renal insufficiency, severe uremia and patients with metabolic disorders of amino acids. Use with caution in patients with severe acidosis and congestive heart failure.
Notice broadcast
1. Drip rate should be strictly controlled. 2. This strain is a carbonate, and a large amount of importation may lead to acid-base imbalance. The balance of electrolyte and acid base should be paid attention to when large amounts of electrolytes are used or used for infusion. 3. Before use, the liquid must be checked in detail. If the bottle is found to be broken, air leakage, discoloration, mildew, precipitation, deterioration and other abnormal phenomena, it should never be used. 4. When it is cold, crystallization may occur. The liquid medicine can be heated to 60ºC and slowly shaken to completely dissolve the crystallization before use. 5. Open a bottle of liquid medicine once used up, the remaining liquid medicine should not be stored for reuse.
Pregnant women and lactating women medication report
This product has not been used in pregnancy and lactation. If necessary, the pros and cons and risks should be weighed. Animal experiments (embryonic toxicity studies on rabbits) show that this product has no direct or indirect harmful effects on reproduction.
Children medication bulletin
This product is not intended for use in children under 2 years of age as the prescription for this product is not appropriate for the needs of these patients. Children over 2 years old have no use experience, so it is not recommended for pediatric patients.
Geriatric medication report
The experiment was not performed and no reliable references were available.
Pharmacology and toxicology
This product has the function of promoting the normal metabolism of human protein, correcting the negative nitrogen balance, supplementing protein and speeding up wound healing. This product can also adjust the plasma amino acid spectrum of patients with liver disease, increase the ratio of straight chain amino acid/aromatic amino acid and nutritional effect, provide tolerable nitrogen source for patients with liver disease, improve the protein level and promote the recovery of liver function.
){kind=link}